U. Gessner

581 total citations
23 papers, 414 citations indexed

About

U. Gessner is a scholar working on Surgery, Emergency Medicine and Psychiatry and Mental health. According to data from OpenAlex, U. Gessner has authored 23 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 3 papers in Emergency Medicine and 3 papers in Psychiatry and Mental health. Recurrent topics in U. Gessner's work include Migraine and Headache Studies (3 papers), Sympathectomy and Hyperhidrosis Treatments (2 papers) and Blood groups and transfusion (2 papers). U. Gessner is often cited by papers focused on Migraine and Headache Studies (3 papers), Sympathectomy and Hyperhidrosis Treatments (2 papers) and Blood groups and transfusion (2 papers). U. Gessner collaborates with scholars based in Switzerland, Germany and United States. U. Gessner's co-authors include Samuel Charache, Georg Schulthess, Bruno Horisberger, Markus Sagmeister, Hartmut Göbel, Geneviève Haag, Robert Lange, Arne May, Gerhard Müller-Schwefe and A. Eikermann and has published in prestigious journals such as Journal of Clinical Investigation, European Heart Journal and Archives of Biochemistry and Biophysics.

In The Last Decade

U. Gessner

23 papers receiving 376 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
U. Gessner Switzerland 9 135 109 77 71 48 23 414
Jun Ai China 13 74 0.5× 26 0.2× 51 0.7× 56 0.8× 6 0.1× 50 581
Klaus Mayer Germany 11 147 1.1× 27 0.2× 60 0.8× 38 0.5× 15 0.3× 34 390
G. Davı̀ Italy 12 302 2.2× 44 0.4× 53 0.7× 43 0.6× 11 0.2× 35 739
N. Bird United Kingdom 12 31 0.2× 102 0.9× 22 0.3× 83 1.2× 56 1.2× 27 490
Mohamed Zedan Egypt 11 18 0.1× 41 0.4× 79 1.0× 55 0.8× 21 0.4× 46 534
Mohan Anand India 15 18 0.1× 34 0.3× 38 0.5× 190 2.7× 28 0.6× 45 889
R. Kannan India 13 42 0.3× 43 0.4× 25 0.3× 23 0.3× 6 0.1× 48 646
B. Giraud France 12 25 0.2× 7 0.1× 57 0.7× 49 0.7× 27 0.6× 36 357
J Moll Poland 16 37 0.3× 13 0.1× 20 0.3× 100 1.4× 20 0.4× 70 757
Damian Quinn United Kingdom 11 125 0.9× 45 0.4× 138 1.8× 7 0.1× 7 0.1× 36 398

Countries citing papers authored by U. Gessner

Since Specialization
Citations

This map shows the geographic impact of U. Gessner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by U. Gessner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites U. Gessner more than expected).

Fields of papers citing papers by U. Gessner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by U. Gessner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by U. Gessner. The network helps show where U. Gessner may publish in the future.

Co-authorship network of co-authors of U. Gessner

This figure shows the co-authorship network connecting the top 25 collaborators of U. Gessner. A scholar is included among the top collaborators of U. Gessner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with U. Gessner. U. Gessner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Göbel, Hartmut, J. Braun, M. Petersen-Braun, & U. Gessner. (2015). Pharmakoökonomischer Nutzen der Selbstmedikation in Deutschland – Empirische Untersuchung am Beispiel von Migräne und Kopfschmerzen. Gesundheitsökonomie & Qualitätsmanagement. 21(1). 23–29. 2 indexed citations
2.
Gessner, U.. (2014). Karl Friedrich Meyer (1884–1974): His ambitions, approach and achievements. Journal of Medical Biography. 24(1). 71–75. 1 indexed citations
3.
Göbel, Hartmut, et al.. (2006). Acetylsalicylsäure bei der Selbstmedikation von Migränekopfschmerzen. Der Schmerz. 21(1). 49–56. 5 indexed citations
4.
Schulz, H.‐U., et al.. (2004). Effects of acetylsalicylic acid on ascorbic acid concentrations in plasma, gastric mucosa, gastric juice and urine a double-blind study in healthy subjects. International Journal of Clinical Pharmacology and Therapeutics. 42(9). 481–487. 12 indexed citations
5.
Schulz, H.‐U., et al.. (2004). Effects of buffered and plain acetylsalicylic acid formulations with and without ascorbic acid on gastric mucosa in healthy subjects. Alimentary Pharmacology & Therapeutics. 19(3). 367–374. 9 indexed citations
6.
Diener, HC, A. Eikermann, U. Gessner, et al.. (2004). Efficacy of 1,000 mg Effervescent Acetylsalicylic Acid and Sumatriptan in Treating Associated Migraine Symptoms. European Neurology. 52(1). 50–56. 38 indexed citations
7.
Gessner, U., et al.. (2000). Economic analysis of terminal care for patients with malignant osteolytic bone disease and pain treated with pamidronate. Supportive Care in Cancer. 8(2). 115–122. 17 indexed citations
8.
Sagmeister, Markus, U. Gessner, Bruno Horisberger, & F Gutzwiller. (1998). [Socioeconomic aspects of the changed mortality rate of coronary disease in Switzerland 1988-1993].. PubMed. 128(10). 356–62. 1 indexed citations
9.
Sagmeister, Markus, et al.. (1997). An economic analysis of ischaemic heart disease in Switzerland. European Heart Journal. 18(7). 1102–1109. 22 indexed citations
10.
Gessner, U.. (1991). Medical Engineering in Switzerland. Journal of Clinical Engineering. 16(1). 61–64. 1 indexed citations
11.
Sagmeister, Markus, Bruno Horisberger, & U. Gessner. (1990). The costs of ischaemic heart disease in Switzerland. Zurich Open Repository and Archive (University of Zurich). 1(1). 5–16. 4 indexed citations
12.
Bloom, Bernard S. & U. Gessner. (1989). Long-Term Technology Assessment: Mortality, Hospitalization, and Work Loss Due to Peptic Ulcer and Gastritis/Duodenitis in the Federal Republic of Germany. International Journal of Technology Assessment in Health Care. 5(2). 215–226. 5 indexed citations
13.
Westerhausen, M., et al.. (1981). Immunological changes following posttraumatic splenectomy. Annals of Hematology. 43(6). 345–353. 7 indexed citations
14.
Keller, Heather & U. Gessner. (1981). The likelihood quotient line, a tool for the assessment of diagnostic validity of clinical chemical tests.. PubMed. 19(12). 1211–2. 3 indexed citations
15.
Gessner, U., et al.. (1977). [Prognosis of local primary breast carcinoma under current therapy].. PubMed. 107(28). 992–4. 2 indexed citations
16.
Meuret, G., et al.. (1976). Neutrophil marrow release. Annals of Hematology. 33(6). 389–402. 8 indexed citations
17.
Talke, H., et al.. (1976). Intrahepatische Cholestase durch N-Propyl-Ajmalin. DMW - Deutsche Medizinische Wochenschrift. 101(18). 699–703. 12 indexed citations
18.
Gessner, U., et al.. (1971). [Effect of isoproterenol on the input impedance of human pulmonary circulation].. PubMed. 37. 284–8. 1 indexed citations
19.
Charache, Samuel, et al.. (1969). Hemoglobin Hasharon (α247 his(CD5)β2): a hemoglobin found in low concentration. Journal of Clinical Investigation. 48(5). 834–847. 39 indexed citations
20.
Gessner, U.. (1963). The theory of electromagnetic flow measurement. Archives of Biochemistry and Biophysics. 102(1). 170–170. 196 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026